2Carroll WD, Dhillon R. Sildenafil as a treatment for pulmonary hypertension. Arch Dis Child,2003,88:827-828.
3Maharaj CH, O'Toole D, Lynch T, et al. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. Reprod Biol Endocrinol,2009,7:34.
4Tantini B,Manes A, Fiumana E, et al. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells. Basic Res Cardiol.2005.100 : 131-138.
5Remillard CV, Yuan JX. TRP channels, CCE, and the pulmonary vascular smooth muscle. Micrecirculation, 2006, 13 : 671-692.
6Wang C, Wang J, Zhao L, et al. Sildenafil inhibits human pulmonary artery smooth muscle cell proliferation by decreasing capacitative Ca^2+ entry. J Pharmacol Sci,2008,108:71-78.
7Li B, Yang L, Shen J, et al. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation. Anesth Analg,2007,105:1034-1041.
8Mikhail GW, Prasad SK, Li W, et al. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J,2004,25:431-436.
9Raposo-Sonnenfeld I, Otero-Gonzalez I, Blanco-Aparicio M, et al. Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome. Rev Esp Cardiol, 2007,60 : 366- 372.
10Chau EM,Fan KY, Chow WH. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. Int J Cardiol,2007,120:301-305.
1Shafazand S,Goldstein MK,Doyle RL,et al.Health-related qualityof life in patients with pulmonary arteri hypertension[J].Chest,2004,126(5):1452-1459.
2Haworth SG,Hislop AA.Treatment and survival in children withpulmonary arterial hytertention:the UK Pulmonary HypertensionSrvice for Children 2001-2006[J].Heart,2009,95(3):312-317.
